Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners

INTRODUCTION: Closed-system transfer devices (CSTDs) were introduced into clinical practice to protect healthcare practitioners (HCPs) from exposure to hazardous drugs. However, ambiguous guidelines have led to confusion as to when CSTD use is required, as institutes are instructed to maintain their...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaira, Manmeet, Guy, Allison L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047104/
https://www.ncbi.nlm.nih.gov/pubmed/34000919
http://dx.doi.org/10.1177/10781552211010928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047104/
https://www.ncbi.nlm.nih.gov/pubmed/34000919
http://dx.doi.org/10.1177/10781552211010928

Ejemplares similares